Predicting the effect on smoking-attributable mortality by reducing cigarette smoking;Forventet effekt på tobaksrelateret dodelighed af nedsat cigaretforbrug

Ugeskrift for Laeger

Volumn 162, Issue 43, 2000, Pages 5772-5777

  Brønnum Hansen, Henrik ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRONCHITIS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DENMARK; FEMALE; HUMAN; LUNG EMPHYSEMA; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTOR; SMOKING; SMOKING CESSATION; STATISTICAL MODEL;

ADULT; AGED; BRONCHITIS; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; DENMARK; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; PULMONARY EMPHYSEMA; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 0041905267     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Juel K. Hvorfor bar danskerne problemer med middellevetiden? Rygningens betydning i de seneste 50 år. Ugeskr Læger 1998; 160: 6800-5.
2. Regeringens folkesundhedsprogram 1999-2008. Sundhedsministeriet: København, 1999.
3. Gunning-Schepers LJ. The health benefits of prevention, a simulation approach. Health Policy 1989; 12: 1-256.
4. Brønnum-Hansen H, Sjøl A. Forudsigelse af udviklingen i dødeligheden af iskæmisk hjertesygdom i Danmark 1982-1991 ved anvendelse af simulationsmodellen Prevent. Ugeskr Læger 1996; 158: 4898-904.
5. Brønnum-Hansen H. How good is the Prevent model for estimating the health benefits of prevention? J Epidemiol Community Health 1999; 53: 300-5.
6. Osler M. Danskernes rygevaner: en rapport. København: Hjerteforeningen, 1992.
7. Nielsen PE, Zacho J, Olsen JA, Olsen CA. Ændringer i danskernes rygevaner 1970-1987. Ugeskr Læger 1988; 150: 2229-33.
8. Nielsen PE, Sørensen JF. Danskernes rygevaner 1988-1993. En opfølgning af tidligere befolkningsundersøgelser. Ugeskr Læger 1995; 157: 3451-6.
9. Van de Mheen PJ, Gunning-Schepers LJ. Differences between studies in reported relative risks associated with smoking: an overview. Public Health Rep 1996; 111: 420-6.
10. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular risk profiles. Am Heart J 1991; 121: 293-8.
11. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 1997; 96: 1089-96.
12. Public health models. Tools for health policy making at national and European level: Biomed project BMH4-CT95-1000. Amsterdam: Institut voor Sociale Geneeskunde, Universiteit van Amsterdam, 1999.
13. Brønnum-Hansen H, Juel K. Estimating mortality due to cigarette smoking. Two methods, same result. Epidemiology 2000; 11: 422-6.
14. Peto R, Lopez AD, Boreham J, Thun M, Heath C. Mortality from tobacco in developed countries; indirect estimation from national vital statistics. Lancet 1992; 339: 1268-78.
15. Sterling TD, Rosenbaum WL, Weinkam JJ. Risk attribution and tobacco-related deaths. Am J Epidemiol 1993; 138: 128-39.
16. Prescott E, Osier M, Hein HO, Borch-Johnsen K, Lange P, Schnohr P et al. Gender and smoking-related risk of lung cancer. Epidemiology 1998; 9: 79-83.